10-Q Filing

LIFESTANCE HEALTH GROUP, INC. CIK: 1845257 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0000950170-22-009328`
Period End Date	20220331
Filing Date	20220511
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	lfst-20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 36 Cash Flow Statement 64 Stockholders Equity 17

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$148.03M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$113.99M	USD	Point-in-time
Patient accounts receivable, net	`AccountsReceivableNetCurrent`	$76.08M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Patient accounts receivable, net	`AccountsReceivableNetCurrent`	$94.99M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$54.32M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$42.41M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$263.30M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$266.52M	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$152.24M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	800.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	800.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$170.93M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$300.36M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	374.25M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$291.18M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	374.32M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	374.32M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	374.25M	shares	Point-in-time
Goodwill	`Goodwill`	$1.20B	USD	Point-in-time
Goodwill	`Goodwill`	$1.23B	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$3.45M	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$3.68M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.66B	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.70B	USD	Point-in-time
Total assets	`Assets`	$1.93B	USD	Point-in-time
Total assets	`Assets`	$1.96B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$15.14M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$14.15M	USD	Point-in-time
Accrued payroll expenses	`EmployeeRelatedLiabilitiesCurrent`	$73.21M	USD	Point-in-time
Accrued payroll expenses	`EmployeeRelatedLiabilitiesCurrent`	$60.00M	USD	Point-in-time
Other accrued expenses	`OtherAccruedLiabilitiesCurrent`	$21.81M	USD	Point-in-time
Other accrued expenses	`OtherAccruedLiabilitiesCurrent`	$26.51M	USD	Point-in-time
Current portion of contingent consideration	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$14.12M	USD	Point-in-time
Current portion of contingent consideration	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$13.49M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.97M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.96M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$116.75M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$125.60M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$177.38M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$157.42M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$57.49M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$50.33M	USD	Point-in-time
Contingent consideration, net of current portion	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$1.12M	USD	Point-in-time
Contingent consideration, net of current portion	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$3.31M	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$54.28M	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$54.28M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$265.33M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$290.27M	USD	Point-in-time
Total liabilities	`Liabilities`	$415.87M	USD	Point-in-time
Total liabilities	`Liabilities`	$382.08M	USD	Point-in-time
COMMITMENT AND CONTINGENCIES (see Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENT AND CONTINGENCIES (see Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - par value $0.01 per share; 25,000 shares authorized as of March 31, 2022 and December 31, 2021; 0 shares issued and outstanding as of March 31,2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - par value $0.01 per share; 25,000 shares authorized as of March 31, 2022 and December 31, 2021; 0 shares issued and outstanding as of March 31,2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock - par value $0.01 per share; 800,000 shares authorized as of March 31, 2022 and December 31, 2021; 374,323 and 374,255 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$3.74M	USD	Point-in-time
Common stock - par value $0.01 per share; 800,000 shares authorized as of March 31, 2022 and December 31, 2021; 374,323 and 374,255 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$3.74M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.90B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.96B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-419.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-357.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.54B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$1.55B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.96B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$1.93B	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
TOTAL REVENUES	`Revenues`	$203.09M	USD	1 Quarter
TOTAL REVENUES	`Revenues`	$143.13M	USD	1 Quarter
Center costs, excluding depreciation and amortization shown separately below	`OtherGeneralExpense`	$99.13M	USD	1 Quarter
Center costs, excluding depreciation and amortization shown separately below	`OtherGeneralExpense`	$148.89M	USD	1 Quarter
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$32.65M	USD	1 Quarter
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$103.37M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$12.23M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$15.68M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$267.95M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$144.01M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-881.00K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-64.85M	USD	1 Quarter
Loss on remeasurement of contingent consideration	`BusinessCombinationRemeasurementGainLossOnContingentConsideration`	$-434.00K	USD	1 Quarter
Loss on remeasurement of contingent consideration	`BusinessCombinationRemeasurementGainLossOnContingentConsideration`	$-307.00K	USD	1 Quarter
Transaction costs	`TransactionCosts`	$278.00K	USD	1 Quarter
Transaction costs	`TransactionCosts`	$-1.53M	USD	1 Quarter
Interest expense	`InterestExpense`	$3.44M	USD	1 Quarter
Interest expense	`InterestExpense`	$8.63M	USD	1 Quarter
Other expense	`OtherExpenses`	-	USD	1 Quarter
Other expense	`OtherExpenses`	$89.00K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-10.56M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-4.15M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-69.00M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.44M	USD	1 Quarter
INCOME TAX BENEFIT	`IncomeTaxExpenseBenefit`	$-6.68M	USD	1 Quarter
INCOME TAX BENEFIT	`IncomeTaxExpenseBenefit`	$-2.76M	USD	1 Quarter
NET LOSS	`ComprehensiveIncomeNetOfTax`	$-8.68M	USD	1 Quarter
NET LOSS	`ComprehensiveIncomeNetOfTax`	$-62.33M	USD	1 Quarter
Accretion of Redeemable Class A units	`PreferredStockAccretionOfRedemptionDiscount`	$36.75M	USD	1 Quarter
Accretion of Redeemable Class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	1 Quarter
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS/MEMBERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-45.43M	USD	1 Quarter
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS/MEMBERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-62.33M	USD	1 Quarter
Net loss per share, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.18	USD	1 Quarter
Net loss per share, basic and diluted	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.15	USD	1 Quarter
Weighted-average shares used to compute basic and diluted net loss per share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	305,538.00	shares	1 Quarter
Weighted-average shares used to compute basic and diluted net loss per share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	350,849.00	shares	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$-8.68M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-62.33M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$12.23M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$15.68M	USD	1 Quarter
Stock and unit-based compensation	`ShareBasedCompensation`	$59.85M	USD	1 Quarter
Stock and unit-based compensation	`ShareBasedCompensation`	$605.00K	USD	1 Quarter
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$295.00K	USD	1 Quarter
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$403.00K	USD	1 Quarter
Loss (gain) on remeasurement of contingent consideration	`LossGainOnRemeasurementOfContingentConsideration`	$-307.00K	USD	1 Quarter
Loss (gain) on remeasurement of contingent consideration	`LossGainOnRemeasurementOfContingentConsideration`	$-434.00K	USD	1 Quarter
Patient accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$18.12M	USD	1 Quarter
Patient accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$3.12M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.04M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$12.06M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.85M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.01M	USD	1 Quarter
Accrued payroll expenses	`IncreaseDecreaseInWorkersCompensationLiabilities`	$12.76M	USD	1 Quarter
Accrued payroll expenses	`IncreaseDecreaseInWorkersCompensationLiabilities`	$7.31M	USD	1 Quarter
Other accrued expenses	`IncreaseDecreaseInOtherAccruedLiabilities`	$5.88M	USD	1 Quarter
Other accrued expenses	`IncreaseDecreaseInOtherAccruedLiabilities`	$4.94M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.91M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.31M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.08M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$27.91M	USD	1 Quarter
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$754.00K	USD	1 Quarter
Acquisitions of businesses, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$22.95M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.84M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-50.85M	USD	1 Quarter
Payments of deferred offering costs	`PaymentsOfStockIssuanceCosts`	$323.00K	USD	1 Quarter
Payments of deferred offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	1 Quarter
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$26.20M	USD	1 Quarter
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$20.00M	USD	1 Quarter
Payments of debt issue costs	`PaymentsOfDebtIssuanceCosts`	$955.00K	USD	1 Quarter
Payments of debt issue costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Payments of long-term debt	`RepaymentsOfLongTermDebt`	$785.00K	USD	1 Quarter
Payments of long-term debt	`RepaymentsOfLongTermDebt`	$331.00K	USD	1 Quarter
Payments of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$5.72M	USD	1 Quarter
Payments of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$1.55M	USD	1 Quarter
Taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$441.00K	USD	1 Quarter
Taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$22.59M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.51M	USD	1 Quarter
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$20.66M	USD	1 Quarter
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-34.04M	USD	1 Quarter
Cash and Cash Equivalents - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$113.99M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$148.03M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.49M	USD	Point-in-time
Cash and Cash Equivalents - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.83M	USD	Point-in-time
CASH AND CASH EQUIVALENTS END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$113.99M	USD	Point-in-time
CASH AND CASH EQUIVALENTS END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$148.03M	USD	Point-in-time
CASH AND CASH EQUIVALENTS END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$39.49M	USD	Point-in-time
CASH AND CASH EQUIVALENTS END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$18.83M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$6.81M	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$3.09M	USD	1 Quarter
Cash paid for taxes, net of refunds	`IncomeTaxesPaidNet`	$3.00K	USD	1 Quarter
Cash paid for taxes, net of refunds	`IncomeTaxesPaidNet`	$-60.00K	USD	1 Quarter
Unpaid deferred offering costs included in accounts payable and other accrued expenses	`UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedExpenses`	-	USD	1 Quarter
Unpaid deferred offering costs included in accounts payable and other accrued expenses	`UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedExpenses`	$1.87M	USD	1 Quarter
Equipment financed through capital leases	`EquipmentFinancedThroughCapitalLeases`	$57.00K	USD	1 Quarter
Equipment financed through capital leases	`EquipmentFinancedThroughCapitalLeases`	$14.00K	USD	1 Quarter
Contingent consideration incurred in acquisitions of businesses	`ContingentConsiderationIncurredInAcquisitionsOfBusinesses`	$2.47M	USD	1 Quarter
Contingent consideration incurred in acquisitions of businesses	`ContingentConsiderationIncurredInAcquisitionsOfBusinesses`	$808.00K	USD	1 Quarter
Acquisition of property and equipment included in liabilities	`PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses`	$7.50M	USD	1 Quarter
Acquisition of property and equipment included in liabilities	`PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses`	$12.32M	USD	1 Quarter

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$997.84M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.54B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$954.01M	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-62.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.68M	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock units (in amount)	`StockIssuedDuringPeriodValueRestrictedStockUnitsReleases`	$-37.00K	USD	1 Quarter
Forfeitures,value	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$-185.00K	USD	1 Quarter
Issuance of common, Value	`StockIssuedDuringPeriodValueNewIssues`	$1.00M	USD	1 Quarter
Accretion of Redeemable Class A units	`PreferredStockAccretionOfRedemptionDiscount`	$36.75M	USD	1 Quarter
Accretion of Redeemable Class A units	`PreferredStockAccretionOfRedemptionDiscount`	-	USD	1 Quarter
Stock and unit-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$605.00K	USD	1 Quarter
Stock and unit-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$60.04M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$997.84M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.54B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$954.01M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.